OHB's €1bn IRIS² Win Gets Lost in the Noise of a Brutal Technical Correction

OHB shares erased gains from €1B SES satellite deal, falling 12% to €183. Despite solid H1 results, valuation concerns persist.

The market's reaction to OHB SE's landmark satellite contract has left even seasoned traders scratching their heads. On Monday, the Bremen-based space company confirmed it had been selected by SES to build 18 satellites for Europe's IRIS² constellation — a deal worth just under €1 billion. The shares responded with an 8.4 percent pop to €205.50. By Tuesday's close, however, virtually all of that gain had evaporated, with the stock tumbling 12 percent to €183.00.

The whipsaw tells a familiar story: investors had already been trimming positions for weeks before the announcement landed, and the contract merely provided fresh liquidity for those looking to exit. Over the past 30 days, OHB shares have now surrendered 22 percent, a slide that began well before SES put pen to paper. The sell-off has been so aggressive that the stock is trading roughly 27 percent below its 50-day moving average of €249.67 — a stark illustration of how quickly sentiment has soured.

A Valuation That Outran Its Fundamentals

The central tension for OHB is straightforward: the company's operational performance, while solid, has not kept pace with the extraordinary rerating its shares have undergone. Revenue for the first half of 2026 reached €627.9 million, up 11 percent year on year, while adjusted EBIT climbed 46 percent to €38.9 million. Adjusted EBITDA rose more than 30 percent to €60 million. The order book stood at €3.304 billion, and the company's total pipeline has been cited at roughly €20 billion.

Impressive as those figures are, they look modest next to a share price that has nearly tripled over the past twelve months and remains up 185 percent on an annual basis despite the recent pullback. Even after the correction, the stock has gained 56 percent since the start of the year. The question investors are now wrestling with is whether the operational momentum — buttressed by IRIS², the full acquisition of MT Aerospace, and a partnership with Rheinmetall on the SATCOMBw 4 programme — can justify a valuation that raced far ahead of the underlying earnings trajectory.

The Bull Case: Capacity to Deliver

Optimists point to several factors that suggest the current weakness is a digestion phase rather than the beginning of a prolonged decline. OHB confirmed its full-year guidance after the strong first-half results, targeting €1.4 billion in total output and an adjusted EBITDA margin between 10.5 and 11 percent. The balance sheet has also been reinforced: a rights issue priced at €300 per share raised up to €510.7 million, while an upsized private placement added €900 million. The equity ratio now stands at 43.3 percent, giving management ample firepower to take on additional large contracts without straining the capital structure.

The first quarter had already demonstrated the company's trajectory, with revenue climbing 18.46 percent to €270.9 million and earnings per share nearly doubling from €0.26 to €0.52. Headcount has grown by half to roughly 4,100 employees, a tangible sign of the workload ahead. Additional wins — including the second-generation PRISMA Earth observation system for the Italian space agency ASI through subsidiary OHB Italia, plus collaborations with Rheinmetall and Schwarz Digits on AI-driven satellite manufacturing — have reinforced the growth narrative.

Several banks initiated coverage in early August with price targets ranging from €250 to €360, with Rothschild taking the most bullish stance. Jefferies, Berenberg and Goldman Sachs also entered the fray, framing the record order situation as a structural growth driver rather than a one-off event. The company's inclusion in the SDAX in mid-August, replacing Klöckner, added further visibility.

The Bear Case: Momentum Has Already Broken

The technical picture, however, is far less forgiving. The stock now sits roughly 26 percent below its 50-day average and around 29 percent beneath its 200-day average — evidence that the medium-term trend had already turned before the latest leg down. Annualised 30-day volatility of 75 percent underscores just how febrile trading in the shares has become. The distance from the record high set in late May remains substantial, suggesting that a meaningful portion of the earlier exuberance has been unwound, but also that the stock is still carrying a heavy valuation premium.

The uncomfortable arithmetic is that an 11 percent revenue increase and a 46 percent EBIT improvement, while respectable, do not obviously justify a tripling of the share price within a year. Should the operational cadence revert to type without further major contract announcements, the risk is that the market gradually marks the valuation down to match the pace of fundamental growth.

What Happens Next

The coming weeks offer several opportunities for management to recalibrate expectations. Executives are scheduled to appear at the Jefferies Industrials Conference on 9-10 September and at the Berenberg & Goldman Sachs German Corporate Conference on 21 September, where they will likely face questions about how the recent order momentum fits into the broader growth outlook. The next hard data point arrives on 12 November with third-quarter results, which will show whether operational growth is keeping pace with market expectations.

For now, the IRIS² contract — with first satellite launches planned for 2029 and services slated to begin in 2030 — is best understood as confirmation of OHB's strategic position within Europe's sovereign satellite communications programme rather than a catalyst that changes the fundamental picture overnight. Whether the current weakness represents a buying opportunity or the start of a longer consolidation will depend on whether the company can translate its pipeline into a steady stream of additional awards — and whether the market's patience holds out in the meantime.